SLC7A8 Antibody (YA7803)
(Synonyms: LAT2; LPI-PC1)SLC7A8 Antibody (YA7803) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to SLC7A8.
-
Host:
Mouse
-
Isotype:
IgG
-
Application:
IHC-P, ICC/IF
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
-
Conjugation:
Non-conjugated
Applications
| Application |
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
|---|---|---|
| Dilution Ratio | 1:100-500 | 1:100-250 |
Product Details
SLC7A8 Antibody (YA7803) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to SLC7A8.
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman, Mouse, Rat
-
Calculated Molecular Weight Predicted band size: 58.2 kDa
Full length human recombinant protein of human SLC7A8 produced in HEK293T cell.
Endogenous
Affinity purified
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Versand
Shipping with blue ice.
Background
-
Function
SLC7A8 associates with SLC3A2 to form a functional heterodimeric complex that translocates small and large neutral amino acids with broad specificity and a stoichiometry of 1:1. Functions as amino acid antiporter mediating the influx of extracellular essential amino acids mainly in exchange with the efflux of highly concentrated intracellular amino acids. Has relatively symmetrical selectivities but strongly asymmetrical substrate affinities at both the intracellular and extracellular sides of the transporter. This asymmetry allows SLC7A8 to regulate intracellular amino acid pools (mM concentrations) by exchange with external amino acids (uM concentration range), equilibrating the relative concentrations of different amino acids across the plasma membrane instead of mediating their net uptake. May play an essential role in the reabsorption of neutral amino acids from the epithelial cells to the bloodstream in the kidney. Involved in the uptake of methylmercury (MeHg) when administered as the L-cysteine or D,L-homocysteine complexes, and hence plays a role in metal ion homeostasis and toxicity. Involved in the cellular activity of small molecular weight nitrosothiols, via the stereoselective transport of L-nitrosocysteine (L-CNSO) across the transmembrane. Imports the thyroid hormone diiodothyronine (T2) and to a smaller extent triiodothyronine (T3) but not rT 3 or thyroxine (T4). Mediates the uptake of L-DOPA. May participate in auditory function[1][2][3][4][5][6][7][8][9][10][11].
-
Subcellular Localization
Cell membrane,Basolateral cell membrane
-
Expression
Tissue_Specificity: Strongest expression is observed in kidney and moderate expression in placenta and brain, followed by liver, prostate, testis, ovary, lymph node, thymus, spleen, skeletal muscle and heart. Also expressed in fetal liver as well as in the retinal pigment epithelial cell line ARPE-19 and the intestinal epithelial cell line Caco-2 -
Isoforms & Post-Translational Modification
Q9UHI5 has four isomers: Q9UHI5-1: 58382 Da (predicted); Q9UHI5-2: 37184 Da (predicted); Q9UHI5-3: 34602 Da (predicted); Q9UHI5-4: 48283 Da (predicted).
-
Subunit
Disulfide-linked heterodimer composed of the catalytic light chain subunit SLC7A8 and the heavy chain subunit SLC3A2
-
SwissProt ID
-
Synonyms
LAT2; LPI-PC1
Documentation